Mutational Shift in FLT3 and NPM1-Positive Acute Myeloid Leukemia (AML) Relative to Therapy and Disease Progression
Priya Velu(University of Pennsylvania), Selina M. Luger(University of Pennsylvania), Jennifer J.D. Morrissette(University of Pennsylvania), Kiarash Salafian(University of Pennsylvania), Adam Bagg(University of Pennsylvania), Chris C.‐S. Hsiung(University of California, San Francisco)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907